Spaces:
Sleeping
Sleeping
Anirudh Balaraman commited on
Revise README structure and project description
Browse filesReorganized and clarified the README content, including the project description and key features.
README.md
CHANGED
|
@@ -15,14 +15,13 @@
|
|
| 15 |
</p>
|
| 16 |
|
| 17 |
# WSAttention-Prostate
|
| 18 |
-
|
| 19 |
-
**Weakly Supervised Attention-Based Deep Learning for Prostate Cancer Characterization from Bi-Parametric Prostate MRI.**
|
| 20 |
-
|
| 21 |
|
| 22 |
## 🚀 Platform Access
|
| 23 |
Real-time inference via [GUI](https://huggingface.co/spaces/anirudh0410/Prostate-Inference)
|
| 24 |
|
| 25 |
-
|
|
|
|
| 26 |
|
| 27 |
Deep learning methods used in medical AI—particularly for csPCa prediction and PI-RADS classification—typically rely on expert-annotated labels for training, which limits scalability to larger datasets and broader clinical adoption. To address this, we employ a two-stage multi-instance learning (MIL) framework pretrained using attention-based weak supervision on scan-level PI-RADS scores. For downstream risk assessment, the PI-RADS classification head is replaced and fine-tuned on a substantially smaller dataset to predict clinically significant prostate cancer (csPCa). Careful preprocessing is applied to mitigate variability arising from cross-site MRI acquisition differences. For further details, please refer to our paper or visit the project website.
|
| 28 |
|
|
|
|
| 15 |
</p>
|
| 16 |
|
| 17 |
# WSAttention-Prostate
|
| 18 |
+
Predicts PI-RADS score and risk of clinically significant prostate cancer (csPCa) from T2-Weighted (T2W), Diffusion Weighted Imaging (DWI) and Apparent Diffusion Coefficient (ADC) sequences of bi-paramteric MRI (bpMRI).
|
|
|
|
|
|
|
| 19 |
|
| 20 |
## 🚀 Platform Access
|
| 21 |
Real-time inference via [GUI](https://huggingface.co/spaces/anirudh0410/Prostate-Inference)
|
| 22 |
|
| 23 |
+
## Weakly Supervised Attention-Based Deep Learning for Prostate Cancer Characterization from Bi-Parametric Prostate MRI.
|
| 24 |
+
|
| 25 |
|
| 26 |
Deep learning methods used in medical AI—particularly for csPCa prediction and PI-RADS classification—typically rely on expert-annotated labels for training, which limits scalability to larger datasets and broader clinical adoption. To address this, we employ a two-stage multi-instance learning (MIL) framework pretrained using attention-based weak supervision on scan-level PI-RADS scores. For downstream risk assessment, the PI-RADS classification head is replaced and fine-tuned on a substantially smaller dataset to predict clinically significant prostate cancer (csPCa). Careful preprocessing is applied to mitigate variability arising from cross-site MRI acquisition differences. For further details, please refer to our paper or visit the project website.
|
| 27 |
|